Nutex Health (NUTX) Operating Leases (2019 - 2026)

Nutex Health has disclosed Operating Leases across 8 years of filings, most recently posting $29.6 million for Q1 2026.

• Operating Leases for Q1 2026 came in at $29.6 million, down 2.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $29.6 million (down 2.36% YoY), and the FY2025 annual result was $30.0 million, down 1.89% from the prior year.
• Operating Leases came in at $29.6 million for Q1 2026 at Nutex Health, down from $30.0 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $30.8 million in Q2 2025 to a low of $91238.0 in Q1 2022.
• The 5-year median for Operating Leases is $19.4 million (2022), against an average of $20.7 million.
• Peak annual rise in Operating Leases reached 28291.31% in 2022, while the deepest fall reached 64.75% in 2022.
• Nutex Health's Operating Leases stood at $19.4 million in 2022, then dropped by 20.37% to $15.5 million in 2023, then soared by 97.79% to $30.6 million in 2024, then retreated by 1.89% to $30.0 million in 2025, then decreased by 1.35% to $29.6 million in 2026.
• The last three Operating Leases figures came in at $29.6 million (Q1 2026), $30.0 million (Q4 2025), and $30.4 million (Q3 2025), per Business Quant data.